Open access
Jul 2026
CHAF1A identified as a candidate biomarker and potential therapeutic target in Burkitt lymphoma through integrated bioinformatics and histopathological analysis.
CHAF1A is identified as a candidate biomarker associated with BL that, in exploratory single-dataset analysis, also correlates with immune-cell infiltration and is nominated as a potential therapeutic target that warrants functional validation in future studies.
Wenyuan Lin, Bei-Li Chen, Zhi-Mei Wu et al.
· Hematology · 0 citations